Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes

NCT03556098 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: glucose-dependent insulinotropic peptide
DRUG: Glucose-Dependent Insulin-Releasing Hormone[3-30]
DRUG: Saline Solution

Sponsor

Steno Diabetes Center Copenhagen